Label: HEXATRIONE 2%- triamcinolone hexacetonide injection, suspension
- NDC Code(s): 59137-570-01
- Packager: Medexus Pharma, Inc.
- Category: HUMAN PRESCRIPTION DRUG LABEL
- DEA Schedule: None
- Marketing Status: Unapproved drug for use in drug shortage
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated January 10, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- HEALTH CARE PROVIDER LETTER
- HOW SUPPLIED
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
HEXATRIONE 2%
triamcinolone hexacetonide injection, suspensionProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:59137-570 Route of Administration INTRA-ARTICULAR Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TRIAMCINOLONE HEXACETONIDE (UNII: I7GT1U99Y9) (TRIAMCINOLONE ACETONIDE - UNII:F446C597KA) TRIAMCINOLONE HEXACETONIDE 40 mg in 2 mL Inactive Ingredients Ingredient Name Strength SODIUM HYDROXIDE (UNII: 55X04QC32I) SORBITOL SOLUTION 70% (UNII: 8KW3E207O2) WATER (UNII: 059QF0KO0R) HYDROCHLORIC ACID (UNII: QTT17582CB) BENZYL ALCOHOL (UNII: LKG8494WBH) POLYSORBATE 80 (UNII: 6OZP39ZG8H) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:59137-570-01 1 in 1 CARTON 03/03/2021 1 2 mL in 1 AMPULE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug for use in drug shortage 03/03/2021 Labeler - Medexus Pharma, Inc. (078811131) Establishment Name Address ID/FEI Business Operations Valdepharm 260128560 manufacture(59137-570)
